| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 300 | 2013 |
| Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration K Poesen, D Lambrechts, P Van Damme, J Dhondt, F Bender, N Frank, ... Journal of Neuroscience 28 (42), 10451-10459, 2008 | 160 | 2008 |
| Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties F Bono, F De Smet, C Herbert, K De Bock, M Georgiadou, P Fons, M Tjwa, ... Cancer cell 23 (4), 477-488, 2013 | 115 | 2013 |
| Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease K Poesen, M De Schaepdryver, B Stubendorff, B Gille, P Muckova, ... Neurology 88 (24), 2302-2309, 2017 | 96 | 2017 |
| Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the− 2578AA genotype D Lambrechts, K Poesen, R Fernandez-Santiago, A Al-Chalabi, R Del Bo, ... Journal of medical genetics 46 (12), 840-846, 2009 | 94* | 2009 |
| Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis E Feneberg, P Oeckl, P Steinacker, F Verde, C Barro, P Van Damme, ... Neurology 90 (1), e22-e30, 2018 | 91 | 2018 |
| Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1 CR De Almodovar, C Coulon, PA Salin, E Knevels, N Chounlamountri, ... Journal of Neuroscience 30 (45), 15052-15066, 2010 | 83 | 2010 |
| VEGF protects motor neurons against excitotoxicity by upregulation of GluR2 E Bogaert, P Van Damme, K Poesen, J Dhondt, N Hersmus, D Kiraly, ... Neurobiology of aging 31 (12), 2185-2191, 2010 | 78 | 2010 |
| Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS P Oeckl, C Jardel, F Salachas, F Lamari, PM Andersen, R Bowser, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17 (5-6), 404-413, 2016 | 58 | 2016 |
| Neuronal FLT1 receptor and its selective ligand VEGF‐B protect against retrograde degeneration of sensory neurons J Dhondt, E Peeraer, A Verheyen, R Nuydens, I Buysschaert, K Poesen, ... The FASEB Journal 25 (5), 1461-1473, 2011 | 53 | 2011 |
| Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis M De Schaepdryver, A Jeromin, B Gille, KG Claeys, V Herbst, B Brix, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (4), 367-373, 2018 | 51 | 2018 |
| Therapeutic potential of VEGF and VEGF-derived peptide in peripheral neuropathies A Verheyen, E Peeraer, D Lambrechts, K Poesen, P Carmeliet, M Shibuya, ... Neuroscience 244, 77-89, 2013 | 51 | 2013 |
| Diagnostic challenges and clinical characteristics of hepatitis E virus–associated Guillain-Barré syndrome O Stevens, KG Claeys, K Poesen, V Saegeman, P Van Damme JAMA neurology 74 (1), 26-33, 2017 | 43 | 2017 |
| Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease K Adamczuk, J Schaeverbeke, HMJ Vanderstichele, J Lilja, N Nelissen, ... Alzheimer's research & therapy 7 (1), 1-11, 2015 | 42 | 2015 |
| Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy A Verheyen, E Peeraer, R Nuydens, J Dhondt, K Poesen, I Pintelon, ... Brain 135 (9), 2629-2641, 2012 | 39 | 2012 |
| Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with amyotrophic lateral sclerosis B Gille, M De Schaepdryver, J Goossens, L Dedeene, J De Vocht, ... Neuropathology and applied neurobiology 45 (3), 291-304, 2019 | 38 | 2019 |
| CLINICAL PERSPECTIVE E Storkebaum, C Ruiz de Almodovar, M Meens, S Zacchigna, M Mazzone, ... Circulation 122 (3), 273-281, 2010 | 38 | 2010 |
| Xenon anaesthesia for patients undergoing off-pump coronary artery bypass graft surgery: a prospective randomized controlled pilot trial L Al Tmimi, J Van Hemelrijck, M Van de Velde, P Sergeant, B Meyns, ... BJA: British Journal of Anaesthesia 115 (4), 550-559, 2015 | 36 | 2015 |
| Detection of myositis-specific antibodies JB Vulsteke, E De Langhe, KG Claeys, D Dillaerts, K Poesen, J Lenaerts, ... Annals of the rheumatic diseases 78 (1), e7-e7, 2019 | 32 | 2019 |
| Diagnostic and prognostic performance of neurofilaments in ALS K Poesen, P Van Damme Frontiers in neurology 9, 1167, 2019 | 31 | 2019 |
Philip Van DammeProfessor of Neuroscience, University of LeuvenVerifierad e-postadress på uzleuven.be
